{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:03:14Z","timestamp":1790758994688,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L258065"],"award-info":[{"award-number":["L258065"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2024-12M-C&T-B-023"],"award-info":[{"award-number":["2024-12M-C&T-B-023"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["GZC20230301"],"award-info":[{"award-number":["GZC20230301"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02947-8","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:59:23Z","timestamp":1782273563000},"page":"2747-2757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and pathological features of oncocytic adrenocortical carcinoma: a retrospective comparative study"],"prefix":"10.1007","volume":"49","author":[{"given":"Jiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songchen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diliyaer","family":"Dilixiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8058-9702","authenticated-orcid":false,"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"8","key":"2947_CR1","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s11864-024-01249-6","volume":"25","author":"JS Russell","year":"2024","unstructured":"Russell JS (2024) Systemic management of advanced adrenocortical carcinoma. Curr Treat Options Oncol 25(8):1063\u20131072. https:\/\/doi.org\/10.1007\/s11864-024-01249-6","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"2947_CR2","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/jc.2005-2639","volume":"91","author":"B Allolio","year":"2006","unstructured":"Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027\u20132037. https:\/\/doi.org\/10.1210\/jc.2005-2639","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2947_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","volume":"23","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Allolio B (2009) Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23(2):273\u2013289. https:\/\/doi.org\/10.1016\/j.beem.2008.10.008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"17","key":"2947_CR4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/nejm199004263221705","volume":"322","author":"JP Luton","year":"1990","unstructured":"Luton JP, Cerdas S, Billaud L et al (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322(17):1195\u20131201. https:\/\/doi.org\/10.1056\/nejm199004263221705","journal-title":"N Engl J Med"},{"issue":"9","key":"2947_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/oncolo\/oyae029","volume":"29","author":"D Chukkalore","year":"2024","unstructured":"Chukkalore D, MacDougall K, Master V, Bilen MA, Nazha B (2024) Adrenocortical carcinomas: molecular pathogenesis, treatment options, and emerging immunotherapy and targeted therapy approaches. Oncol 29(9):738\u2013746. https:\/\/doi.org\/10.1093\/oncolo\/oyae029","journal-title":"Oncol"},{"key":"2947_CR6","doi-asserted-by":"publisher","DOI":"10.1530\/eje-18-0608","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T et al (2018) European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-18-0608","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2947_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/oncolo\/oyae084","volume":"29","author":"J Del Rivero","year":"2024","unstructured":"Del Rivero J, Else T, Hallanger-Johnson J et al (2024) A review of mitotane in the management of adrenocortical cancer. Oncol 29(9):747\u2013760. https:\/\/doi.org\/10.1093\/oncolo\/oyae084","journal-title":"Oncol"},{"issue":"5","key":"2947_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/s2213-8587(24)00378-4","volume":"13","author":"M Fassnacht","year":"2025","unstructured":"Fassnacht M, Puglisi S, Kimpel O, Terzolo M (2025) Adrenocortical carcinoma: a practical guide for clinicians. Lancet Diabetes Endocrinol 13(5):438\u2013452. https:\/\/doi.org\/10.1016\/s2213-8587(24)00378-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2947_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41379-018-0077-8","volume":"31","author":"K Renaudin","year":"2018","unstructured":"Renaudin K, Smati S, Wargny M et al (2018) Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation. Mod Pathol 31(11):1708\u20131716. https:\/\/doi.org\/10.1038\/s41379-018-0077-8","journal-title":"Mod Pathol"},{"issue":"1","key":"2947_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Erickson LA, Juhlin CC et al (2022) Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol 33(1):155\u2013196. https:\/\/doi.org\/10.1007\/s12022-022-09710-8","journal-title":"Endocr Pathol"},{"issue":"3","key":"2947_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/106689690401200304","volume":"12","author":"M Bisceglia","year":"2004","unstructured":"Bisceglia M, Ludovico O, Di Mattia A et al (2004) Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 12(3):231\u2013243. https:\/\/doi.org\/10.1177\/106689690401200304","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"2947_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.urology.2004.04.023","volume":"64","author":"K Tanaka","year":"2004","unstructured":"Tanaka K, Kumano Y, Kanomata N et al (2004) Oncocytic adrenocortical carcinoma. Urol 64(2):376\u2013377. https:\/\/doi.org\/10.1016\/j.urology.2004.04.023","journal-title":"Urol"},{"issue":"1","key":"2947_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-025-09857-0","volume":"36","author":"A Prinzi","year":"2025","unstructured":"Prinzi A, Guarnotta V, Di Dalmazi G et al (2025) Multicentric retrospective analysis of oncocytic adrenocortical carcinoma: insights into clinical and management strategies. Endocr Pathol 36(1):11. https:\/\/doi.org\/10.1007\/s12022-025-09857-0","journal-title":"Endocr Pathol"},{"issue":"2","key":"2947_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A et al (2014) Adrenocortical carcinoma. Endocr Rev 35(2):282\u2013326. https:\/\/doi.org\/10.1210\/er.2013-1029","journal-title":"Endocr Rev"},{"key":"2947_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12216925","author":"E Coppola Bottazzi","year":"2023","unstructured":"Coppola Bottazzi E, Gambardella C, Mongardini FM et al (2023) Prognosis of adrenal oncocytic neoplasms (AONs): literature review of 287 cases and presentation of the oldest patient. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12216925","journal-title":"J Clin Med"},{"issue":"9","key":"2947_CR16","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1245\/s10434-022-11626-w","volume":"29","author":"AS Shirali","year":"2022","unstructured":"Shirali AS, Zagzag J, Chiang YJ et al (2022) Differences in clinicopathologic behavior of oncocytic adrenocortical neoplasms and conventional adrenocortical carcinomas. Ann Surg Oncol 29(9):5555\u20135563. https:\/\/doi.org\/10.1245\/s10434-022-11626-w","journal-title":"Ann Surg Oncol"},{"key":"2947_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2023.100759","volume":"37","author":"R Lib\u00e9","year":"2023","unstructured":"Lib\u00e9 R, Huillard O (2023) Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease. Cancer Treat Res Commun 37:100759. https:\/\/doi.org\/10.1016\/j.ctarc.2023.100759","journal-title":"Cancer Treat Res Commun"},{"issue":"10418","key":"2947_CR18","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/s0140-6736(23)01961-x","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing\u2019s syndrome. Lancet 402(10418):2237\u20132252. https:\/\/doi.org\/10.1016\/s0140-6736(23)01961-x","journal-title":"Lancet"},{"issue":"11","key":"2947_CR19","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.4158\/dscr-2020-0567","volume":"26","author":"K Kiseljak-Vassiliades","year":"2020","unstructured":"Kiseljak-Vassiliades K, Bancos I, Hamrahian A et al (2020) American association of clinical endocrinology disease state clinical review on the evaluation and management of adrenocortical carcinoma in an adult: a practical approach. Endocr Pract 26(11):1366\u20131383. https:\/\/doi.org\/10.4158\/dscr-2020-0567","journal-title":"Endocr Pract"},{"issue":"4","key":"2947_CR20","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4):1710\u20131715","journal-title":"J Immunol"},{"key":"2947_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.110","author":"I Miller","year":"2018","unstructured":"Miller I, Min M, Yang C et al (2018) Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2018.06.110","journal-title":"Cell Rep"},{"issue":"3","key":"2947_CR22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li LT, Jiang G, Chen Q, Zheng JN (2015) Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 11(3):1566\u20131572. https:\/\/doi.org\/10.3892\/mmr.2014.2914","journal-title":"Mol Med Rep"},{"issue":"4","key":"2947_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.surg.2019.05.049","volume":"166","author":"JK Mills","year":"2019","unstructured":"Mills JK, Khalil M, Pasieka J, Kong S, Xu Y, Harvey A (2019) Oncocytic subtypes of adrenal cortical carcinoma: aggressive in appearance yet more indolent in behavior? Surgery 166(4):524\u2013533. https:\/\/doi.org\/10.1016\/j.surg.2019.05.049","journal-title":"Surgery"},{"issue":"3","key":"2947_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"Beuschlein F, Weigel J, Saeger W et al (2015) Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 100(3):841\u2013849. https:\/\/doi.org\/10.1210\/jc.2014-3182","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2947_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2026.106092","volume":"11","author":"O Kimpel","year":"2026","unstructured":"Kimpel O, Cosentini D, Calabrese A et al (2026) Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study. ESMO Open 11(3):106092. https:\/\/doi.org\/10.1016\/j.esmoop.2026.106092","journal-title":"ESMO Open"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02947-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02947-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02947-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:54Z","timestamp":1790757234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02947-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2947"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02947-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was done in accordance with the Declaration of Helsinki and local regulations and was approved by the ethics committee of Peking Union Medical College Hospital (Approval Number: I-23PJ912157).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from all participants included.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}